Pharmarise Holdings Corporation

2796

JP3802320006

Drug Retailers

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
639 ^JPY	-2.59%		-1.54%	-3.18%

Apr. 11	Pharmarise Holdings’ Attributable Profit Down 15% in Fiscal Nine Months on Higher Expenses Following M&A	MT
Apr. 10	Pharmarise Holdings Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024	CI

Pharmarise Holdings Corporation announces an Equity Buyback for 1,416,800 shares, representing 12.07% for ¥1,032 million.

January 11, 2024 at 03:00 am EST

Pharmarise Holdings Corporation (TSE:2796) announces a share repurchase program. Under the program, the company will repurchase up to 1,416,800 shares, representing 12.07% of its total shares outstanding excluding treasury shares, for a total of ¥1,032 million. The purpose of repurchase program is to carry out flexible management and capital policies in response to changes in the corporate environment.

The repurchase program is valid till January 14, 2025.

Latest news about Pharmarise Holdings Corporation

Pharmarise Holdings’ Attributable Profit Down 15% in Fiscal Nine Months on Higher Expenses Following M&A	Apr. 10	MT
Pharmarise Holdings Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024	Apr. 10	CI
Tranche Update on Pharmarise Holdings Corporation's Equity Buyback Plan announced on January 11, 2024.	Mar. 14	CI
Pharmarise Holdings Corporation announces an Equity Buyback for 1,416,800 shares, representing 12.07% for ¥1,032 million.	Jan. 11	CI
Pharmarise's Fiscal H1 Attributable Profit Soars as Net Sales Rise	Jan. 10	MT
Pharmarise Holdings Corporation authorizes a Buyback Plan.	Jan. 10	CI
Pharmarise Holdings Corporation entered into stock transfer agreement to acquire GOOD AID Inc. from Kotoshino Co., Ltd. and Yuta Hattori.	Jan. 10	CI
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024	Jan. 10	CI
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024	23-10-11	CI
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Six Months and Full Year of Fiscal Year Ending May 31, 2024	23-10-11	CI
Pharmarise Holdings Corporation acquired Nine Dispensing Pharmacies in Tokyo, Niigata, and Fukushima.	23-08-09	CI
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024	23-07-11	CI
Pharmarise Holdings Corporation Announces Commemorative Dividend for the Fiscal Year Ending May 31, 2024	23-07-11	CI
Pharmarise Holdings Corporation Declares Dividend for the Fiscal Year Ending May 31, 2023, Payable on August 31, 2023	23-07-11	CI
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Six Months and Full Year of Fiscal Year Ending May 31, 2024	23-07-11	CI
Pharmarise Logs 35% Drop in FY23 Nine-month Profit on Higher Utility Expenses, Lower Drugstore Sales	23-04-11	MT
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2023	23-04-10	CI
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2023	23-04-10	CI
Pharmarise Holdings Corporation entered into basic agreement to acquire Two Dispensing Pharmacies in Mie Prefecture.	23-02-13	CI
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Full Year of Fiscal Year Ending May 31, 2023	23-01-12	CI
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2023	23-01-12	CI
Pharmarise's Fiscal Q1 Attributable Profit Soars 75%	22-10-14	MT
Pharmarise Holdings Corporation Provides Consolidated Earnings Guidance for the Six Months and Full Year of Fiscal Year Ending May 31, 2023	22-10-13	CI
Pharmarise Holdings Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2023	22-10-13	CI
Pharmarise Logs 5% Jump in FY22 Attributable Profit, Maintains Final Dividend	22-07-19	MT

Chart Pharmarise Holdings Corporation

Duration

Period

More charts

Company Profile

Pharmarise Holdings Corporation is a Japan-based holding company primarily engaged in the dispensing pharmacy businesses. Along with its subsidiaries and associated companies, the Company operates in five business segments. The Dispensing Pharmacy segment is engaged in the operation of dispensing pharmacies, which prescribe medicines to general patients based on prescriptions issued by medical institutions. The Merchandising segment consists of the cosmetics sales business, the convenience store management business and the drug store management business. The Medical Document Storage and Management segment is engaged in the storage and management of paper medical records and X-ray films. The Medical Mall Management segment is a business related to medical malls operated at JR Tower Office Plaza Sapporo in JR Sapporo Station. Others segment includes temporary staffing business and sales of stationery.

Sector

Drug Retailers

Calendar

2024-07-10 - Q4 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
PHARMARISE HOLDINGS CORPORATION	-3.18%	45.64M
RAIA DROGASIL S.A.	-12.86%	8.57B
AIN HOLDINGS INC.	+32.95%	1.32B
QOL HOLDINGS CO., LTD.	+6.76%	419M
NIHON CHOUZAI CO.,LTD.	+5.93%	282M
SALUS, LJUBLJANA, D. D.	+10.56%	224M
GREEN CROSS HEALTH LIMITED	-8.26%	85.07M
MEDICAL IKKOU GROUP CO.,LTD.	+20.94%	59.57M

Retail - Drugs without Grocery